Pharma 2024 _ Event Postponement
We would like to inform you that due to unforeseen circumstances beyond the organizer control, the "11th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems" (Pharma-2024), originally scheduled for March 18-20 in Singapore, has been rescheduled to take place from September 19-21, 2024, in Rome, Italy.
If you have already confirmed your participation at the event, please note that your registration and accommodation (if previously booked with us) will automatically be transferred to the new dates.
For any further information or inquiries, please do not hesitate to contact us at pharmadds@magnusconference.com or call us at +1 (702) 988 2320.
Virtual healthcare refers to the “virtual visits” that take place between patients and clinicians via technology – the visual and audio connectivity that allows “virtual” interactions to take place in real time, from practically any location. A videoconference between a doctor and a patient at home can be considered a virtual visit. Pharma companies have been collaborating with digital and data companies for some years to figure out how to effectively use virtual health and how it might improve processes throughout the business continuum. Virtual health technologies will allow the pharmaceutical sector to have a larger engagement with patients and clinicians across many touchpoints.
- Telehealth
- Revolutionizing Healthcare
- Recent Trends in Virtual Healthcare
A C Matin
Stanford University, United States
Tudor Arvinte
Biopharmaceutics University of Geneva, Switzerland
Richard Denk
SKAN AG, Switzerland
Consolato M Sergi
University of Ottawa, Canada
Sergey Suchkov
Institute for Biotechnology & Global Health of the RosBioTech and A.I. Evdokimov MGMSU, Russian Federation
Luis Jesus Villarreal Gomez
Autonomous University of Baja California, Mexico
Miroslav Radenkovic
University of Belgrade, Serbia
Ruchika Bajaj
University of California, United States
Gurpreet Singh
Vice President, IQVIA, United Kingdom
Bhupendra Gopalbhai Prajapati
Ganpat University, IndiaSubmit your abstract Today
Title : Nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, present successes and future prospects
A C Matin, Stanford University, United States
Title : Points to consider for the manufacturing of cell and gene therapies
Richard Denk, SKAN AG, Switzerland
Title : Personalized and precision medicine (PPM) as a unique healthcare model to be set up via biodesign, bio- and chemical engineering, translational applications, and upgraded business modeling to secure the human healthcare and biosafety
Sergey Suchkov, Institute for Biotechnology & Global Health of the RosBioTech and A.I. Evdokimov MGMSU, Russian Federation
Title : Thymoquinone-induced cellular and mitochondrial health in hepatocellular and cholangiocellular carcinoma
Consolato M Sergi, University of Ottawa, Canada
Title : Pharmacological features of sparsentan, a novel dual endothelin and angiotensin receptor antagonist
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Antimicrobial electrospun fiber-based structures and their possible use as systems for delivering drugs to the skin
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Understanding ABC transporters to navigate human diseases
Ruchika Bajaj, University of California, United States
Title : Antibodies (Abs) with functionality (Ab-Proteases) as a new generation of translational tools designed get healthcare model re-armed and drug design enriched
Sergey Suchkov, Institute for Biotechnology & Global Health of the RosBioTech and A.I. Evdokimov MGMSU, Russian Federation
Title : Microemulsion based in situ gel of erythromycin for ocular ailments
Dasharath Muljibhai Patel, Graduate School of Pharmacy, India
Title : Drug discoveries and challenges for polymeric medical packaging devices
Anupam Chanda, Bioxytran Inc, India